Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion.

Knol, J A; Walker, S C; Robertson, J M; Yang, Z; DeRemer, S; Stetson, P L; Ensminger, W D; Lawrence, T S

Knol, J A; Walker, S C; Robertson, J M; Yang, Z; DeRemer, S; Stetson, P L; Ensminger, W D; Lawrence, T S.

Affiliation

Knol JA; Department of Surgery, University of Michigan Medical School, Ann Arbor 48109, USA.

Cancer Res ; 55(17): 3687-91, 1995 Sep 01.

Article in En | MEDLINE | ID: mdl-7641176

Subject(s)

Bromodeoxyuridine/metabolism; Colorectal Neoplasms; Liver Neoplasms/metabolism; Liver/metabolism; Adult; Aged; Bromodeoxyuridine/administration & dosage; DNA/metabolism; DNA, Neoplasm/metabolism; Female; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial/adverse effects; Liver Neoplasms/pathology; Liver Neoplasms/secondary; Male; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bromodeoxyuridine / Colorectal Neoplasms / Liver / Liver Neoplasms Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Res Year: 1995 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links